Fluxion Biosciences and Rubicon Genomics, Inc. to Collaborate on Circulating Tumor Cell Applications

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Fluxion Biosciences, Inc. today announced an initial agreement to partner with Rubicon Genomics in a reagent supply and collaboration program. The collaboration will integrate enrichment methods for rare cells using Fluxion’s IsoFlux System with Rubicon’s technology for the preparation and amplification of rare cell DNA or RNA using the Rubicon NovaPLEX™ family of sample preparation kits.